Evaluation of 99mTc-ubiquicidin 29-41 scintigraphy in differentiation of bacterial infection from sterile inflammation in diabetic foot

Iranian Journal of Nuclear Medicine

Volumn 18, Issue 2, 2010, Pages 20-28

  Fard Esfahani, Armaghan ^a   Beiki, Davood ^a   Fallahi, Babak ^a   Mohajeri Tehrani, Mohammad Reza ^b   Gharaie, Mohammad Reza ^a   Rouhipour, Nahid ^b   Dehghanian, Mehrdad ^a   Saghari, Mohsen ^a   Emami Ardekani, Alireza ^a   Eftekhari, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

99mTc UBI 29 41; Diabetic foot; Infection; Radiolabeled peptide; Ubiquicidin

Indexed keywords

RADIOPHARMACEUTICAL AGENT; UBIQUICIDIN TC 99M; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BONE SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC FOOT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; INFLAMMATION; KIDNEY; LIVER; MALE; OSTEOMYELITIS; SCINTIGRAPHY; SENSITIVITY ANALYSIS;

EID: 79961006847     PISSN: 16812824     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cavanagh PR, Lipsky BA, Bradbury AW, Botek G. Treatment for diabetic foot ulcers. Lancet. 2005;366(9498):1725-1735. (Pubitemid 41587453)
2. Crawford F, McCowan C, Dimitrov BD, Woodburn J, Wylie GH, Booth E et al. The risk of foot ulceration in people with diabetes screened in community settings: findings from a cohort study. QJM. 2011;104(5):403-410.
3. Bell DP Jr. Diabetic foot ulcers: current treatment options and new developments. Surg Technol Int. 2010;20:97-105.
4. Abbott CA, Garrow AP, Carrington AL, Morris J, Van Ross ER, Boulton AJ et al. Foot ulcer risk is lower in South-Asian and african-Caribbean compared with European diabetic patients in the U.K.: the North-West diabetes foot care study. Diabetes Care. 2005;28(8):1869-1875. (Pubitemid 41060956)
5. Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288-1293. (Pubitemid 44125924)
6. Jeffcoate WJ, Harding KG Diabetic foot ulcers. Lancet 2003;361:1545-1551. (Pubitemid 36566350)
7. Yuh WT, Corson JD, Baraniewski HM, Rezai K, Shamma AR, Kathol MH et al. Osteomyelitis of the foot in diabetic patients: evaluation with plain film, 99mTc-MDP bone scintigraphy, and MR imaging. AJR Am J Roentgenol. 1989;152(4):795-800. (Pubitemid 19091940)
8. Cavanagh PR, Young MJ, Adams JE, Vickers KL, Boulton AJ. Radiographic abnormalities in the feet of patients with diabetic neuropathy. Diabetes Care. 1994;17(3):201-209. (Pubitemid 24065517)
9. Ledermann HP, Morrison WB. Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: MR Imaging. Semin Musculoskelet Radiol. 2005;9(3):272-283. (Pubitemid 41362339)
10. Palestro CJ. The current role of gallium imaging in infection. Semin Nucl Med. 1994;24(2):128-141.
11. Rajendran JG, Graham MM. In-111-labeled leukocyte infection imaging: false-positive results caused by wound dressing and hematoma. Clin Nucl Med. 1999;24(2):126-127. (Pubitemid 29061751)
12. Fischman AJ, Rauh D, Solomon H, Babich JW, Tompkins RG, Kroon D et al. In vivo bioactivity and biodistribution of chemotactic peptide analogs in nonhuman primates. J Nucl Med. 1993;34(12):2130-2134. (Pubitemid 24002956)
13. 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44(6):920-926. (Pubitemid 39663404)
14. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42(5):788-794.
15. 99mTc-UBI for detecting infection foci in patients with fever in study. Nucl Med Commun. 2010;31(10):889-895.
16. Meléndez-Alafort L, Rodríguez-Cortés J, Ferro-Flores G, Arteaga De Murphy C, Herrera-Rodríguez R, Mitsoura E et al. Biokinetics of (99m)Tc-UBI 29-41 in humans. Nucl Med Biol. 2004;31(3):373-379.
17. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27(3):292-301. (Pubitemid 30167699)
18. Ertugrul BM, Savk O, Ozturk B, Cobanoglu M, Oncu S, Sakarya S. The diagnosis of diabetic foot osteomyelitis: examination findings and laboratory values. Med Sci Monit. 2009;15(6):CR307-312.
19. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293(2):217-228. (Pubitemid 40095873)
20. Al-Wahbi AM. Impact of a diabetic foot care education program on lower limb amputation rate. Vasc Health Risk Manag. 2010;6:923-934.
21. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39(7):885-910. (Pubitemid 39328144)
22. El-Maghraby TA, Moustafa HM, Pauwels EK. Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imaging. 2006;50(3):167-192. (Pubitemid 44649658)
23. Palestro CJ, Love C. Nuclear medicine and diabetic foot infections. Semin Nucl Med. 2009;39(1):52-65.
24. Littenberg B, Mushlin AI. Technetium bone scanning in the diagnosis of osteomyelitis: a meta-analysis of test performance. Diagnostic Technology Assessment Consortium. J Gen Intern Med. 1992;7(2):158-164.
25. Akhtar MS, Qaisar A, Irfanullah J, Iqbal J, Khan B, Jehangir M et al. Antimicrobial peptide 99mTc-ubiquicidin 29-41 as human infection-imaging agent: clinical trial. J Nucl Med. 2005;46(4):567-573. (Pubitemid 41716399)
26. Laverman P, Bleeker-Rovers CP, Corstens FHM, Boerman OC, Oyen WJG. Development of Infection and Inflammation Targeting Compounds. Curr Radiopharm. 2008;1:42-48.
27. Arteaga de Murphy C, Gemmel F, Balter J. Clinical trial of specific imaging of infections. Nucl Med Commun. 2010;31(8):726-733.
28. 99mTc-UBI 29-41 scintigraphy for specific detection of experimental multidrug-resistant Staphylococcus aureus bacterial endocarditis. Q J Nucl Med Mol Imaging. 2010;54(4):442-450.
29. 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections. Eur J Nucl Med Mol Imaging. 2007;34(8):1302-1309. (Pubitemid 47290662)
30. 99mTc-Labeled UBI 29-41 peptide for monitoring the efficacy of antibacterial agents in mice infected with Staphylococcus aureus. J Nucl Med. 2004;45(2):321-326.
31. Powlson AS, Coll AP. The treatment of diabetic foot infections. J Antimicrob Chemother. 2010;65 Suppl 3:iii3-9.
32. Hunt JA. Foot infections in diabetes are rarely due to a single microorganism. Diabet Med. 1992;9(8):749-752.
33. 99mTc-labeled antimicrobial peptide ubiquicidin (29-41) accumulates less in Escherichia coli infection than in Staphlococcus aureus infection. J Nucl Med. 2004;45(5):849-856.